{"id":"cggv:c551a092-b6ed-406d-828d-58446b5aa1cfv1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"cggv:c551a092-b6ed-406d-828d-58446b5aa1cf_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10020","date":"2024-07-02T16:00:00.000Z","role":"Approver"},{"id":"cggv:c551a092-b6ed-406d-828d-58446b5aa1cf_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10020","date":"2024-07-02T14:41:13.133Z","role":"Publisher"}],"curationReasons":{"id":"cg:NewCuration"},"earliestArticle":{"id":"https://pubmed.ncbi.nlm.nih.gov/24056717","type":"dc:BibliographicResource","dc:abstract":"The regulated proliferation and differentiation of neural stem cells before the generation and migration of neurons in the cerebral cortex are central aspects of mammalian development. Periventricular neuronal heterotopia, a specific form of mislocalization of cortical neurons, can arise from neuronal progenitors that fail to negotiate aspects of these developmental processes. Here we show that mutations in genes encoding the receptor-ligand cadherin pair DCHS1 and FAT4 lead to a recessive syndrome in humans that includes periventricular neuronal heterotopia. Reducing the expression of Dchs1 or Fat4 within mouse embryonic neuroepithelium increased progenitor cell numbers and reduced their differentiation into neurons, resulting in the heterotopic accumulation of cells below the neuronal layers in the neocortex, reminiscent of the human phenotype. These effects were countered by concurrent knockdown of Yap, a transcriptional effector of the Hippo signaling pathway. These findings implicate Dchs1 and Fat4 upstream of Yap as key regulators of mammalian neurogenesis.","dc:creator":"Cappello S","dc:date":"2013","dc:title":"Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development."},"evidence":[{"id":"cggv:c551a092-b6ed-406d-828d-58446b5aa1cf_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:35a9e5a1-4e9a-4954-a2b3-46b8845c2998_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:35a9e5a1-4e9a-4954-a2b3-46b8845c2998","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Weeks","ageValue":1,"allele":{"id":"cggv:e5d4d7e5-a3c9-424e-ac0e-4fd95f10888a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003737.4(DCHS1):c.2503G>T (p.Gly835Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145412"}},"detectionMethod":"targeted sequencing of 231 genes within homozygosity mapped region of interest ","firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0002079","obo:HP_0012745","obo:HP_0002650","obo:HP_0011968","obo:HP_0012385","obo:HP_0000774","obo:HP_0000894","obo:HP_0032409","obo:HP_0000218","obo:HP_0000486","obo:HP_0001252","obo:HP_0009879","obo:HP_0032388"],"secondTestingMethod":"Other","sex":"Female","variant":{"id":"cggv:9f266cf8-988f-470b-900a-8844ab42429d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:e5d4d7e5-a3c9-424e-ac0e-4fd95f10888a"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24056717"},"rdfs:label":"patient D1"},{"id":"cggv:9f266cf8-988f-470b-900a-8844ab42429d","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:9f266cf8-988f-470b-900a-8844ab42429d_variant_evidence_item"}],"strengthScore":1,"dc:description":"homozygous proven or predicted null variant awarded 2 points per GCEP discussion. For some reason points are doubled so I'll assign 1 point to reach a total of 2 points"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:ae5007d1-acab-4f8a-ba28-6bdc3506db7e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:ae5007d1-acab-4f8a-ba28-6bdc3506db7e","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Hours","ageValue":1,"allele":{"id":"cggv:fa10c499-d5ec-4d23-9d4a-3a28b86fcfbe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003737.4(DCHS1):c.2543del (p.Thr848AsnfsTer30)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145414"}},"detectionMethod":"targeted sequencing of 231 genes in homozygosity mapped region of interest ","firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0012745","obo:HP_0001252","obo:HP_0000938","obo:HP_0001629","obo:HP_0001263","obo:HP_0000405","obo:HP_0012385","obo:HP_0002079","obo:HP_0000415","obo:HP_0000327","obo:HP_0001642","obo:HP_0040079","obo:HP_0000286","obo:HP_0000960"],"secondTestingMethod":"Other","sex":"Male","variant":{"id":"cggv:7c14e4dd-e2c5-4d3f-9897-ebd1a673fae7_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:fa10c499-d5ec-4d23-9d4a-3a28b86fcfbe"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24056717"},"rdfs:label":"patient D2.1"},{"id":"cggv:7c14e4dd-e2c5-4d3f-9897-ebd1a673fae7","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:7c14e4dd-e2c5-4d3f-9897-ebd1a673fae7_variant_evidence_item"}],"strengthScore":1,"dc:description":"homozygous proven or predicted null variant awarded 2 points per GCEP discussion. For some reason points are doubled so I'll assign 1 point to reach a total of 2 points"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:c551a092-b6ed-406d-828d-58446b5aa1cf_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":4.2},{"id":"cggv:e2f803c9-bc26-48e9-bf8f-0e453de7e3cf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e2f803c9-bc26-48e9-bf8f-0e453de7e3cf","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Hours","ageValue":1,"allele":{"id":"cggv:1eb62ed2-9a3f-4786-b869-9aee5e0a0c7d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003737.4(DCHS1):c.7109A>T (p.Asn2370Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145415"}},"detectionMethod":"targeted sequencing of 231 genes in homozygosity mapped region of interest ","firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0000774","obo:HP_0000327","obo:HP_0009879","obo:HP_0002779","obo:HP_0000286","obo:HP_0001252","obo:HP_0032388","obo:HP_0011968","obo:HP_0001263","obo:HP_0000938","obo:HP_0000405","obo:HP_0002751"],"previousTesting":false,"secondTestingMethod":"Other","sex":"Female","variant":{"id":"cggv:dba05dcf-8082-4760-bf14-eb09a133cb3a_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1eb62ed2-9a3f-4786-b869-9aee5e0a0c7d"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/24056717"},"rdfs:label":"patient D3"},{"id":"cggv:dba05dcf-8082-4760-bf14-eb09a133cb3a","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:dba05dcf-8082-4760-bf14-eb09a133cb3a_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Awarded 0.2 points per GCEP discussion"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:8d4264d8-a318-49ac-8062-7932b3a37cd9_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"cggv:8d4264d8-a318-49ac-8062-7932b3a37cd9","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":[{"id":"cggv:3b5a933f-00a4-4153-8b2e-4af0f054f80a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003737.4(DCHS1):c.590C>T (p.Pro197Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5861126"}},{"id":"cggv:e3298365-1b69-4a3b-b905-c8f12778e45f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003737.4(DCHS1):c.7001C>T (p.Thr2334Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5859713"}}],"detectionMethod":"proband exome sequencing, parental variant presence confirmation using Sanger seq","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002650","obo:HP_0000044","obo:HP_0000286","obo:HP_0001249","obo:HP_0000407","obo:HP_0010311","obo:HP_0000327","obo:HP_0000938","obo:HP_0045025"],"sex":"Female","variant":[{"id":"cggv:d06772e1-2f88-4661-bd91-7c3a67a68c31_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:e3298365-1b69-4a3b-b905-c8f12778e45f"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/29046692","type":"dc:BibliographicResource","dc:abstract":"We report a female patient with endocrine abnormalities, hypogonadotropic hypogonadism and amazia (breasts aplasia/hypoplasia but normal nipples and areolas) in a rare syndrome: Van Maldergem syndrome (VMS).","dc:creator":"Sotos J","dc:date":"2017","dc:title":"A patient with van Maldergem syndrome with endocrine abnormalities, hypogonadotropic hypogonadism, and breast aplasia/hypoplasia."}},{"id":"cggv:75e0d9b3-8ab6-480a-94bc-ec6145dccde8_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:3b5a933f-00a4-4153-8b2e-4af0f054f80a"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29046692"}],"rdfs:label":"patient 1"},{"id":"cggv:75e0d9b3-8ab6-480a-94bc-ec6145dccde8","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"cggv:75e0d9b3-8ab6-480a-94bc-ec6145dccde8_variant_evidence_item"},{"id":"cggv:75e0d9b3-8ab6-480a-94bc-ec6145dccde8_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Transfected HEK cell Western blot shows no impact for variant p.Pro197Leu on DCHS1 protein levels (PMID: 26258302)\n"}],"strengthScore":0.5},{"id":"cggv:d06772e1-2f88-4661-bd91-7c3a67a68c31","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Inconclusive","evidence":[{"id":"cggv:d06772e1-2f88-4661-bd91-7c3a67a68c31_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":4.2},{"id":"cggv:c551a092-b6ed-406d-828d-58446b5aa1cf_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:c551a092-b6ed-406d-828d-58446b5aa1cf_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:766ec01a-5d94-49cd-8078-84e6142f913f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:0a5221f7-9ac5-42db-a7db-4d945450c343","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"neuronal heterotopia seen in brain MRI of reported patients. \n\nOf note, generalized constitutional KO of DCHS1 results in neonatal lethality(PMID: 21303848)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24056717","rdfs:label":"DCHS1 conditional knockdown mouse"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2,"dc:description":" Homozygous DCSH1 neonatal lethally is inconsistent with human phenotype. However, conditional DCHS1 KO recapitulated cerebral migration deficit. Assign 2 points after GCEP discussion of experimental evidence"}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Moderate","sequence":8647,"specifiedBy":"GeneValidityCriteria10","strengthScore":6.2,"subject":{"id":"cggv:56e87d31-2105-4be8-8f13-24785c4844b6","type":"GeneValidityProposition","disease":"obo:MONDO_0017813","gene":"hgnc:13681","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"*DCHS1 *was first reported in relation to autosomal recessive entities van Maldergem syndrome in 1992 (van Maldergem PMID: 1633641). At least three variants (e.g. missense, in-frame indel, nonsense, frameshift, large deletion, complex rearrangement, etc) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, experimental data. \n\nVariants in *DCHS1 *have been reported in individuals with van Maldergem syndrome (OMIM: 601390) and mitral valve prolapse 2 (OMIM:607829). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found difference in inheritance pattern and phenotypic variability. Therefore, van Maldergen syndrome (OMIM: 601390) and mitral valve prolapse 2 (OMIM:607829) have been split into different disease entities. The Brain Malformations GCEP performed curation for van Maldergem syndrome (OMIM: 601390) only. \n\nThree variants (2 LoF, 1 missense) in this gene have been reported in at least 3 probands in 2 publications (PMID: 24056717, 22473091). Variants in this gene segregated with disease in 0 additional family members. This gene-disease relationship is supported by shRNA knockdown (electroporation) of DCHS1 in developing mouse brain at E13, evaluated E16-18 or P7 (PMID: 21303848). Treated animals developed cerebral development abnormalities, significant reduction of proliferating cells reaching the cortical plate. At P7, cells fail to migrate, accumulated below the gray matter forming region of neuronal heterotopia. This phenotype corresponds to neuronal heterotopia seen on patient brain MRI imaging. \n\nIn summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Brain Malformations GCEP on the meeting date 6/11/2024.\n","dc:isVersionOf":{"id":"cggv:c551a092-b6ed-406d-828d-58446b5aa1cf"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}